BR0306730A - Processo e intermediários para agentes antidiabéticos de piridazinona - Google Patents

Processo e intermediários para agentes antidiabéticos de piridazinona

Info

Publication number
BR0306730A
BR0306730A BR0306730-0A BR0306730A BR0306730A BR 0306730 A BR0306730 A BR 0306730A BR 0306730 A BR0306730 A BR 0306730A BR 0306730 A BR0306730 A BR 0306730A
Authority
BR
Brazil
Prior art keywords
diabetic
pyridazinone
intermediates
antidiabetic agents
relates
Prior art date
Application number
BR0306730-0A
Other languages
English (en)
Inventor
Norma Jacqueline Tom
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0306730A publication Critical patent/BR0306730A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"PROCESSO E INTERMEDIáRIOS PARA AGENTES ANTIDIABéTICOS DE PIRIDAZINONA". A presente invenção refere-se a um processo para preparar inibidores de aldose redutase de piridazinona que são úteis na prevenção e/ou tratamento de complicações diabéticas tais como neuropatia diabética, retinopatia diabética, nefropatia diabética, cardiomiopatia diabética, microangiopatia diabética e macroangiopatia diabética nos mamíferos. A invenção também refere-se a novos intermediários úteis na preparação daqueles inibidores de aldose redutase.
BR0306730-0A 2002-01-09 2003-01-03 Processo e intermediários para agentes antidiabéticos de piridazinona BR0306730A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34767902P 2002-01-09 2002-01-09
PCT/IB2003/000013 WO2003057691A1 (en) 2002-01-09 2003-01-03 Process and intermediates for pyridazinone antidiabetic agents

Publications (1)

Publication Number Publication Date
BR0306730A true BR0306730A (pt) 2004-12-21

Family

ID=23364775

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0306730-0A BR0306730A (pt) 2002-01-09 2003-01-03 Processo e intermediários para agentes antidiabéticos de piridazinona

Country Status (22)

Country Link
US (1) US6759534B2 (pt)
EP (1) EP1463725B1 (pt)
JP (1) JP2005514421A (pt)
KR (1) KR100604502B1 (pt)
CN (1) CN1269814C (pt)
AR (1) AR038267A1 (pt)
AT (1) ATE302201T1 (pt)
AU (1) AU2003200847A1 (pt)
BR (1) BR0306730A (pt)
CA (1) CA2472331A1 (pt)
DE (1) DE60301324T2 (pt)
DK (1) DK1463725T3 (pt)
ES (1) ES2246464T3 (pt)
HU (1) HUP0500031A2 (pt)
IL (1) IL162594A0 (pt)
MX (1) MXPA04005646A (pt)
PL (1) PL371258A1 (pt)
PT (1) PT1463725E (pt)
RU (1) RU2278116C2 (pt)
TW (1) TWI250980B (pt)
WO (1) WO2003057691A1 (pt)
ZA (1) ZA200404798B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE348100T1 (de) * 2001-03-30 2007-01-15 Pfizer Prod Inc Zwischenprodukten für die herstellung von pyridazinon aldose reductase inhibitoren.
CN103333144B (zh) * 2013-06-17 2014-12-10 温州大学 一种2-硫基-3-卤代苯并呋喃化合物及其合成方法和用途
CN105732552B (zh) * 2016-04-12 2017-12-01 天津师范大学 2位或3‑位硫代苯并呋喃化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3328770A1 (de) * 1983-08-10 1985-02-28 Basf Ag, 6700 Ludwigshafen Pyridazinon-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
ATE348100T1 (de) * 2001-03-30 2007-01-15 Pfizer Prod Inc Zwischenprodukten für die herstellung von pyridazinon aldose reductase inhibitoren.

Also Published As

Publication number Publication date
ZA200404798B (en) 2006-02-22
CN1615307A (zh) 2005-05-11
WO2003057691A1 (en) 2003-07-17
IL162594A0 (en) 2005-11-20
ATE302201T1 (de) 2005-09-15
RU2004121026A (ru) 2006-01-10
MXPA04005646A (es) 2004-12-06
KR100604502B1 (ko) 2006-07-25
DE60301324D1 (de) 2005-09-22
DK1463725T3 (da) 2005-11-21
EP1463725B1 (en) 2005-08-17
PL371258A1 (en) 2005-06-13
US6759534B2 (en) 2004-07-06
RU2278116C2 (ru) 2006-06-20
TW200302098A (en) 2003-08-01
DE60301324T2 (de) 2006-05-24
PT1463725E (pt) 2005-10-31
EP1463725A1 (en) 2004-10-06
TWI250980B (en) 2006-03-11
AU2003200847A1 (en) 2003-07-24
US20030162969A1 (en) 2003-08-28
HUP0500031A2 (hu) 2005-04-28
CN1269814C (zh) 2006-08-16
HK1072598A1 (en) 2005-09-02
AR038267A1 (es) 2005-01-12
ES2246464T3 (es) 2006-02-16
CA2472331A1 (en) 2003-07-17
JP2005514421A (ja) 2005-05-19
KR20040072710A (ko) 2004-08-18

Similar Documents

Publication Publication Date Title
BRPI0409913A (pt) peça de trabalho com camada de material temperado que contém alcr e processo de produção
BRPI0510593A (pt) composições para afetar a perda de peso
MXPA04000622A (es) Pirazolilcarboxanilidas como funguicidas.
BR0013081A (pt) Pirimidino-2,4,6-trionas inibidoras de metaloproteinases
BRPI0517423A (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
DOP2002000545A (es) Moléculas pequeñas para el tratamiento del crecimiento celular anormal
BRPI0512987A (pt) processo para preparar compostos, composto, uso do mesmo, e, material de revestimento termicamente curável, curável por radiação ou de cura dupla
ATE191225T1 (de) Thermisch härtbare, wässrige zusammensetzungen
GT200100016A (es) Pirido[2,3,-d]pirimidin-2,7-diaminas inhibidoras de cinasas.
BRPI0314133A8 (pt) Processo para isolamento de epotilona b, métodos para cultivo de microorganismo que produza epotilona a ou b e para purifiação de apotilona
BR0318503A (pt) quinolinas substituìdas como inibidores de enzima proteìna tirosina cinase
BRPI0408888A (pt) processo para a preparação de derivados de 1-n-(fenil)-2-n-(fenil) pirrolidina-1,2-dicarboxamida e derivados de ácido 1-(fenilcarbamoil) pirrolidina-2-carboxìlico como intermediários
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR9808854A (pt) Processo para preparação de um composto, e, composto
BRPI0416479A (pt) derivado quinazolina, composição farmacêutica, e, processo para a preparação de um derivado de quinazolina
BR9814855A (pt) Processo para tratamento antimicrobiano de microrganismos e/ou vìrus, e, composição antimicrobiana.
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.
BR0110689A (pt) Composição fungicida, e, métodos para intensificar a atividade fungicida de etaboxam, e para controlar fitopatógenos indesejados
CL2004000804A1 (es) Procedimiento de preparacion en una sola etapa de n-(n'-glicilo substituida)-2-cianopirrolidina.
BRPI0411209A (pt) uso de derivados isoindolinona como inseticidas
BRPI0606358A2 (pt) uso de pelo menos um aminoditiol, processo e kit para a deformação permanente dos cabelos e aminotióis
BRPI0412910A (pt) derivados de nicotinamida úteis como inibidores de pde4
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BRPI0507010A (pt) vidrado cerámico antimicrobiano

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O E 7O ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010.